An assessment of peripheral immunity in patients with sarcoidosis using measurements of serum vitamin D3, cytokines and soluble CD23

Clinical and Experimental Immunology

Volumn 110, Issue 1, 1997, Pages 92-97

  Bansal, A S ^a,c   Bruce, J ^a   Hogan, P G ^a   Allen, R K ^b  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

^b THE PRINCE CHARLES HOSPITAL   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Cytokines; Sarcoidosis; SCD23; Vitamin D3

Indexed keywords

CD23 ANTIGEN; COLECALCIFEROL; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLONAL ANERGY; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HUMAN; HUMORAL IMMUNITY; IMMUNOREGULATION; MACROPHAGE ACTIVATION; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PRIORITY JOURNAL; SARCOIDOSIS; VITAMIN BLOOD LEVEL;

EID: 0030869707     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.1997.492-ce1389.x     Document Type: Article

References (34)

1. Hunninghake GW, Crystal RG. Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity. N Eng Med J 1981; 305:429-34.
2. James DG, Jones Williams W. Immunology of sarcoidosis. Am J Med 1982; 72:5-8.
3. Saint-Remy JR, Mitchell DN, Cole PJ. Variations in immunoglobulin levels and circulating immune complexes in sarcoidosis. Correlation with extent of disease and duration of symtoms. Am Rev Resp Dis 1983; 127:22-27.
4. DuBois RM, Kirby M, Balbi B, Saltini C, Crystal RG. T lymphocytes that accumulate in the lung in sarcoidosis have evidence of recent stimulation of the T cell antigen receptor. Am. Rev Respir Dis 1992; 145:1205-11.
5. Steffen M, Petersen J, Oldigs M, Karmeier A, Magnussen H, Thiel HG, Raedler A. Increased secretion of tumor necrosis factor-alpha, interleukin 1 beta and interleukin 6 by alveolar macrophages from patients with sarcoidosis. J Allergy Clin Immunol 1993; 91:939-49.
6. Moller DR, Forman JD, Liu MC et al. Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis. J Immunol 1996; 156:4952-60.
7. Howard M, O'Garra A. Biological properties of interleukin 10. Immunol Today 1992; 13:198-200.
8. Muller K, Haahr PM, Diemont M, Rieneck K, Kharazmi A, Bendtzen K. 1,25-Dihydroxyvitamin D3 inhibits cytokine production by human blood monocytes at the post-transcriptional level. Cytokine 1992; 4:506-12.
9. Bansal AS, Cochrane S, Haeney MR, Bhavnani M, Pumphrey RSH, Wilson PB. Serum soluble CD23 in conditions with hypogammaglobulinaemia and varying B cell numbers. Clin Exp Immunol 1994; 97:239-41.
10. Delespesse G, Suter U, Mossalayi D et al. Expression, structure and function of the CD23 antigen. Adv Immunol 1991; 49:149-91.
11. Gordon J. CD23 and B cell activation. Clin Exp Allergy 1992; 22:199-204.
12. Bansal AS, Ollier W, Marsh MN, Humphrey RSH, Wilson PB. Variations in serum sCD23 in conditions with either enhanced humoral or cell-mediated immunity. Immunology 1993; 79:285-89.
13. Allen RKA, Smith I, Fong KM, McNeil KD. A proposal to establish a world wide data base for sarcoidosis. Sarcoidosis 1992; 9:S267-268.
14. Baudouin SV, du Bois RM. Disease activity. In: Geraint-James D, ed. Sarcoidosis and other granulomatous disorders. New York: Marcel Dekker Inc. 1994; 573-95.
15. Thomas PD, Hunninghake GW. Current concepts of the pathogenesis of sarcoidosis. Am Rev Respir Dis 1987; 135:747-60.
16. Bansal AS, Thomson A, Le Gros G, Hogan PG, Kerlin P, Strong R, Steadman C. Serum levels of interleukins 8 and 10, interferon γ, granulocyte-macrophage colony stimulating factor and soluble CD23 in patients with primary sclerosing cholangitis. Autoimmunity (in press).
17. Bansal AS, Roberts T, Hay EM, Kay R, Pumphrey RSH, Wilson PB. Soluble CD23 levels are elevated in the serum of patients with primary Sjögren's syndrome and SLE. Clin Exp Immunol 1992; 89:452-5.
18. Devergne O, Emilie D, Peuchmaur M, Crevon MC, D'Agay MF, Galanaud P. Production of cytokines in sarcoid lymph nodes: preferential expression of interleukin-1 beta and interferon gamma genes. Hum Pathol 1992; 23:317-23.
19. Asano M, Minagawa T, Ohmichi M, Hiraga Y. Detection of endogenous cytokines in sera or in lymph nodes obtained from patients with sarcoidosis. Clin Exp Immunol 1991; 84:92-96.
20. + T cells in the affected organs of sarcoidosis in patients. Clin Exp Immunol 1995; 102:399-405.
21. Prior C, Haslam PL. In vivo levels and in vitro production of interferon gamma in fibrosing interstitial lung disease. Clin Exp Immunol 1992; 88:280-7.
22. Prior C, Haslam PL. Increased levels of serum interferon-gamma in pulmonary sarcoidosis and relationship with response to corticosteroid therapy. Am Rev Respir Dis 1991; 143:53-60.
23. Bertran G, Arzt E, Ernesto R, Mosca C, Nahmod V. Inhibition of interferon gamma production by peripheral blood mononuclear leukocytes of patients with sarcoidosis. Chest 1992; 101:996-9.
24. Dancescu M, Rubio-Trujillo M, Biron G, Delespesse G, Sarfati M. Interleukin 4 protects chronic lymphocytic leukaemic B cells from death by apoptosis and upregulates Bcl-2 expression. J Exp Med 1992; 176:1319-26.
25. Bansal AS, MacGregor AJ, Pumphrey RSH, Ollier WER, Silman AJ, Wilson PB. Increased levels of sCD23 in rheumatoid arthritis are related to disease status. Clin Exp Rheumatol 1994; 12:281-5.
26. Cush JJ, Splawski JB, Thomas R, McFarlin JE, Schulze-Koops H, Davis LS, Fujita K, Lipsky PE. Elevated interleukin-10 in patients with rheumatoid arthritis. Arthritis Rheum 1995; 38:96-104.
27. Bäumer I, Gernot Z, Schlaak M, Müller-Quernheim J. Th1/Th2 cell distribution in pulmonary sarcoidosis. Am J Resp Cell Mol Biol 1997; 16:171-7.
28. Kataria YP. Cutaneous granulomata in response to injection with autoclaved bronchoalveolar lavage cell preparation in sarcoidosis patients. In: Grassi C, Rizzato G, Pozzi E, eds. Sarcoidosis. Amsterdam: Excerpta Medica 1988:139-42.
29. Semenzato G, Agostini C, Chilosi M. Immunology and immunohistochemistry. In: Geraint-James D, Sarcoidosis and other granulomatous disorders. Lung biology in health and disease. New York: Marcel Dekker, 1994; 73:153-79.
30. Pinkston P, Bitterman PB, Crystal RG. Spontaneous release of interleukin-2 by lung T lymphocytes in active pulmonary sarcoidosis. N Eng J Med 1983; 308:793-800.
31. Robinson BWS, McLemore TL, Crystal RG. Gamma interferon is spontaneously released by alveolar macrophages and lung T cells in patients with sarcoidosis. J Clin Invest 1985; 75:1488-95.
32. Adams JS, Gacad MA, Diz MM, Nadler JL. A role for endogenous arachidonate metabolites in the regulated expression of the 25-hydroxylation reaction in cultured alveolar macrophages from patients with sarcoidosis. J Clin Endocrin Metab 1990; 70:595-600.
33. Flint KC, Pozniak AL, Hudspith BN, Brostoff J, Geraint-James D, Mel Johnson N. Production of immune (gamma) interferon by bronchoalveolar cells and peripheral blood mononuclear cells of subjects with sarcoidosis. Chest 1986; 89:181S-182S.
34. Swider C, Laba A, Moniewska A, Gerdes J, Flad HD, Lange A. Presence of mRNA for interferon gamma (IFN-γ) in blood mononuclear cells is associated with an active stage I disease. Clin Exp Immunol 1995; 100:401-5.